Form D · Biotechnology
COSMICA Inc.
San Francisco, CA · CIK 0001981924
Offering snapshot reported Jun 16, 2023 · SEC filing
- Reported sold
- $200K Offering amount: $2M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 3, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 16, 2023 | Initial | $200,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-484472
Simple Agreement for Future Equity (SAFE)
Source: Form D, filed Jun 16, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| David Furman | Director, Executive |
| Claire Guarry | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
350 Townsend Street #575
San Francisco, CA, 94107
San Francisco, CA, 94107